Search Results - William Malatestinic
- Showing 1 - 1 results of 1
-
1
Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA by Andrew Blauvelt, Alyssa Garrelts, William Malatestinic, Julie Birt, Baojin Zhu, Meghan Feely
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book